Publication | Closed Access

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)

Radiation MedicineMedicineReal-world DataCancer ManagementGerman Expanded-access ProgramBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyDefinitive ChemoradiotherapyLung CancerHealth Sciences